Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleHarnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?AuthorsLelliott, Emily J.; Sheppard, Karen E.; McArthur, Grant A.SubjectsHORMONE receptor positive breast cancer; IPILIMUMAB; CYCLIN-dependent kinase inhibitors; PEMBROLIZUMAB; REGULATORY T cells; TUMOR suppressor proteins; CYTOTOXIC T cells; MELANOMAPublicationNPJ Precision Oncology, 2022, Vol 6, Issue 1, p1ISSN2397-768XPublication typeArticleDOI10.1038/s41698-022-00273-9